Synchroneuron
VerifiedBiopharmaceutical company developing therapies for tardive dyskinesia and other related movement disorders.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$80—120m (Dealroom.co estimates Jul 2014.)
Duxbury Massachusetts (HQ)
Authorizing premium user...